Filing Flows › 8-K events › Zeo ScientifiX
Zeo ScientifiX: entry into a material definitive agreement
Form 8-K filed Oct 26, 2026 · items 1.01
Entry into a material definitive agreementPluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
What the filing says
On October 26, ZEO and Pluri Inc. (Nasdaq and TASE: PLUR) issued a joint press release announcing that they had entered into a definitive strategic agreement to expand the parties’ U.S. manufacturing and commercialization platform serving the regenerative medicine, aesthetics, wellness, and longevity markets. A copy of
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Zeo ScientifiX’s other material 8-Ks
- Nov 3, 2026 — Other events ZEO ScientifiX Makes Industry History as First Facility to Achieve AABB’s Newly Established Quality
- Oct 30, 2026 — Entry into a material definitive agreement
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.